Physician
Bobby Buka, M.D., P.C.
Bobby Buka, M.D., P.C. was paid $58.55M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoBOBBY BUKA, M.D., P.C.
NEW YORK, NY 10038
NEW YORK, NY 10038
33aNPI1134349954assigned 04/26/2007
33bProvider typeDermatology Physician
28Total paid$58.55M
24GClaims638,610
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in New York
Rank by total paid#1 of 349
Median peer was paid$26K
This provider vs. median2,294×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,909 | $1.42M | |
| 2019 | 18,109 | $1.25M | |
| 2020 | 41,359 | $3.06M | |
| 2021 | 75,645 | $6.93M | |
| 2022 | 119,445 | $11.46M | |
| 2023 | 180,371 | $16.73M | |
| 2024incomplete | 185,772 | $17.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 172,438 | 162,869 | $14.41M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 87,276 | 84,499 | $10.90M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15% | 74,985 | 74,898 | $8.59M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 48,045 | 48,012 | $8.26M |
| 17110 | 5.1% | 25,631 | 21,826 | $3.00M | |
| 17360 | 4.9% | 21,261 | 20,581 | $2.85M | |
| 11900 | 3.8% | 41,251 | 37,886 | $2.22M | |
| 96910 | 3.0% | 15,692 | 4,890 | $1.75M | |
| 10040 | 2.5% | 14,453 | 13,526 | $1.48M | |
| 11901 | 1.9% | 16,184 | 15,124 | $1.13M | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.7% | 16,685 | 16,349 | $996K |
| 11102 | 1.1% | 6,637 | 6,527 | $651K |
44 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 9,417 | $445K |
| 88312 | <1% | 2,892 | $370K | |
| 11104 | <1% | 2,096 | $280K | |
| 10060 | <1% | 1,296 | $155K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,806 | $139K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,503 | $106K |
| 88342 | <1% | 520 | $92K | |
| 88304 | <1% | 2,588 | $91K | |
| 17111 | <1% | 567 | $80K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 60,265 | $67K |
| 95044 | <1% | 218 | $63K | |
| 12031 | <1% | 208 | $54K | |
| 99385 | <1% | 453 | $39K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 365 | $33K |
| 11402 | <1% | 280 | $30K | |
| 96900 | <1% | 1,439 | $27K | |
| 11103 | <1% | 423 | $25K | |
| 99386 | <1% | 252 | $24K | |
| 17000 | <1% | 465 | $23K | |
| 99243 | <1% | 227 | $23K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 256 | $23K |
| 54065 | <1% | 92 | $22K | |
| 11100 | <1% | 186 | $18K | |
| 13101 | <1% | 39 | $14K | |
| 12032 | <1% | 43 | $13K | |
| 54056 | <1% | 79 | $12K | |
| 11300 | <1% | 94 | $10K | |
| 15788 | <1% | 27 | $9K | |
| 13121 | <1% | 14 | $6K | |
| 81025 | <1% | 661 | $5K | |
| 15853 | <1% | 371 | $4K | |
| 13131 | <1% | 12 | $4K | |
| 11422 | <1% | 29 | $3K | |
| 11403 | <1% | 25 | $3K | |
| 11301 | <1% | 25 | $3K | |
| J3490 | Unclassified drugs | <1% | 872 | $2K |
| 64650 | <1% | 29 | $2K | |
| 17340 | <1% | 47 | $2K | |
| 11400 | <1% | 14 | $2K | |
| 11442 | <1% | 12 | $1K | |
| 11720 | <1% | 69 | $1K | |
| 17003 | <1% | 60 | $622.21 | |
| J3590 | Unclassified biologics | <1% | 1,682 | $170.20 |
| 36415 | Collection of venous blood by venipuncture | <1% | 54 | $106.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBUKA, ROBERT (CEO)